PATENT CLAIM ANALYSIS

Application Number: 15861444
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["544", "283000"]

Abstract:
Polymorphs of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. Processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed.

Claim (Index 7):
The method of  claim 6 , wherein the cancer is ErbB2 positive.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.32258
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14923172', '14351835', '14351840', '12933044', '14570019']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7817491084107853
- 35 USC 102 Novelty (BERT): 0.6289176881137117
- Combined Prediction Score: 0.7664659663810779
- Mean Citation Score: 418.13936
- Max Citation Score: 620.1506
- Similarity Product: 517.9578465151429

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test